Status:
COMPLETED
Endovascular Treatment of Aorto-iliac Occlusions
Lead Sponsor:
Clinical Centre of Serbia
Conditions:
Aorto-Iliac Occlusive Disease
Iliac Artery Occlusion
Eligibility:
All Genders
18+ years
Brief Summary
This study compares early and long-term results of the endovascular treatment among patients with different types of aorto-iliac occlusions.
Detailed Description
Endovascular treatment has been increasingly applied as a therapeutic option for aorto-iliac occlusive disease during the last decade, becoming the first-line treatment for many of the Trans-Atlantic ...
Eligibility Criteria
Inclusion
- Patient has aorto-iliac occlusions type B, C \& D according to TASC-II classification
- Patient suffers from severe claudication (Rutherford 3) or critical limb ischemia (Rutherford 4 and 5)
- Patients fulfilling criteria for endovascular treatment of aorto-iliac occlusion according to criteria of the participating centres.
Exclusion
- Patients with associated abdominal or iliac aneurysm, restenotic lesions, acute thrombi or dissections,
- Patients who experienced an initial technical failure
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03824730
Start Date
January 1 2013
End Date
September 1 2018
Last Update
January 31 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Center of Serbia
Belgrade, Serbia, 11000
2
Institute for Cardiovascular Diseases Dedinje
Belgrade, Serbia, 11000